Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?

Metabolic syndrome is characterized by a combination of obesity, hypertension, insulin resistance, dyslipidemia, and impaired glucose tolerance. This multifaceted syndrome is often accompanied by a hyperdynamic circulatory state characterized by increased blood pressure, total blood volume, cardiac...

Descripción completa

Detalles Bibliográficos
Autor principal: Dincer, U Deniz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340112/
https://www.ncbi.nlm.nih.gov/pubmed/22563249
http://dx.doi.org/10.2147/DMSO.S30005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340112/
https://www.ncbi.nlm.nih.gov/pubmed/22563249
http://dx.doi.org/10.2147/DMSO.S30005

Ejemplares similares